Integrated BioPharma, Inc.

INBP

US45811V1052

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 18:46:54 14/05/2024 BST			5-day change	1st Jan Change
0.22 ^USD	+1.38%		+0.82%	-10.28%

05-10	Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-12	Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023

September 15, 2023 at 10:21 pm

Integrated BioPharma, Inc. reported earnings results for the fourth quarter ended June 30, 2023. For the fourth quarter, the company reported sales was USD 12.99 million compared to USD 13.27 million a year ago. Net income was USD 0.04 million compared to USD 1.49 million a year ago.

Latest news about Integrated BioPharma, Inc.

Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-10	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-12	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-09	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	15/09/23	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	15/09/23	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	11/05/23	CI
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	21/03/23	CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	17/03/23	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	10/02/23	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	10/11/22	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	13/09/22	CI
Integrated Biopharma, Inc. Announces Change in Directors	21/06/22	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q1 Revenue $15.6M	12/05/22	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	12/05/22	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M	10/02/22	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	10/02/22	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $12.8M	10/11/21	MT
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	10/11/21	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	02/09/21	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	13/05/21	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020	12/02/21	CI
Integrated BioPharma : Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $15.2M	12/11/20	MT
Integrated Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	12/11/20	CI
Integrated Biopharma, Inc. Appoints Eric Friedman as Director and to the Audit Committee of the Board of Directors	09/11/20	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020	23/09/20	CI

Chart Integrated BioPharma, Inc.

Duration

Period

More charts

Company Profile

Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.

Sector

Pharmaceuticals

Calendar

11/09/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INTEGRATED BIOPHARMA, INC.	-10.28%	6.62M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B